Aurinia Pharmaceuticals (AUPH) Capital Expenditures Growth (1y) (2021 - 2026)
Aurinia Pharmaceuticals (AUPH) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Aurinia Pharmaceuticals |
2.08 Bn |
1.70 Bn |
71.20 Mn |
129.41% |
| Date | Value |
|---|
| Mar 31, 2026 |
129.41% |
| Dec 31, 2025 |
28.57% |
| Sep 30, 2025 |
-23.53% |
| Jun 30, 2025 |
-23.44% |
| Mar 31, 2025 |
41.67% |
| Dec 31, 2024 |
-81.27% |
| Sep 30, 2024 |
180.95% |
| Jun 30, 2024 |
-27.68% |
| Mar 31, 2024 |
-96.54% |
| Dec 31, 2023 |
123.13% |
| Sep 30, 2023 |
-362.50% |
| Jun 30, 2023 |
353.85% |
| Mar 31, 2023 |
339.24% |
| Dec 31, 2022 |
114.97% |
| Sep 30, 2022 |
-98.86% |
| Jun 30, 2022 |
-98.89% |
| Mar 31, 2022 |
-92.40% |
| Dec 31, 2021 |
63.02% |
| Sep 30, 2021 |
-5.91% |
| Jun 30, 2021 |
1,111.07% |
